Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.200
-0.090 (-3.93%)
At close: Feb 21, 2025, 4:00 PM
2.180
-0.020 (-0.91%)
After-hours: Feb 21, 2025, 7:54 PM EST
Stereotaxis Employees
Stereotaxis had 122 employees as of December 31, 2023. The number of employees decreased by 8 or -6.15% compared to the previous year.
Employees
122
Change (1Y)
-8
Growth (1Y)
-6.15%
Revenue / Employee
$206,090
Profits / Employee
-$187,648
Market Cap
185.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
STXS News
- 8 days ago - Stock Market Sleeps On Stereotaxis MAGiC CE Mark - Seeking Alpha
- 18 days ago - Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewsWire
- 23 days ago - Stereotaxis Announces First GenesisX Robotic System Order - GlobeNewsWire
- 26 days ago - Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter - GlobeNewsWire
- 5 weeks ago - Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology - GlobeNewsWire
- 2 months ago - Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA - GlobeNewsWire
- 2 months ago - Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems - GlobeNewsWire
- 2 months ago - Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025 - Seeking Alpha